This study was aimed at figuring out whether DHA could ameliorate the Crohn's colitis by activating GPR120 and whether GPR120 could be a potential therapeutic target for CD by mediating the inflammatory pathway. This evidence concerns the gene FFAR4 and Crohn's colitis.